Veterinary Medicine Information website

Gallifen 200 mg/ml suspension for use in drinking water for chickens and pheasants

Authorised
  • Fenbendazole

Product identification

Medicine name:
Gallifen 200 mg/ml suspension for use in drinking water for chickens and pheasants
Active substance:
  • Fenbendazole
Target species:
  • Chicken
  • Pheasant
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Fenbendazole
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Eggs
        0
        day
      • Meat and offal
        8
        day
      • Meat and offal
        6
        day
    • Pheasant
      • Eggs
        0
        day
      • Meat and offal
        6
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC13
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:
  • White rectangular HDPE bottle of 1 litre with vertically see-through bar with an LDPE insert closed with white PP tamper- evident screw cap with a LDPE sealing disk.
  • White HDPE canisters with white HDPE ribbed tamper-evident screw cap of 5 litres.
  • White HDPE canisters with white HDPE ribbed tamper-evident screw cap of 2.5 litres.
  • White cylindrical High Density Polyethylene (HDPE) bottle with white polypropylene (PP) screw tamper-evident closure of 1 litre.
  • White cylindrical High Density Polyethylene (HDPE) bottle with white polypropylene (PP) screw tamper-evident closure of 125 ml.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet AD
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 105076
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0579/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 5/07/2024

Summary of Product Characteristics

English (PDF)
Published on: 30/06/2024
Updated on: 13/03/2026
Download